Wide Ranks

IRON

Disc Medicine, Inc.

64.55

Top Statistics
Market Cap 1 B Forward PE -12.19 Revenue Growth 0.00 %
Current Ratio 19.36 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -11.51 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 487 M Total Cash Per Share 16.38 Total Debt 1 M
Total Debt To Equity 0.3820 Current Ratio 19.36 Book Value Per Share 15.73
All Measures
Short Ratio 392.00 % Message Board Id finmb_641326926 Shares Short Prior Month 1 M
Return On Equity -0.2503 City Watertown Uuid 72cfeced-8656-3c79-9e87-bdc6b1aa7ddf
Previous Close 62.65 First Trade Date Epoch Utc 1 B Book Value 15.73
Total Debt 1 M Volume 136997 Price To Book 4.10
Last Split Date 1 B Fifty Two Week Low 25.60 Total Cash Per Share 16.38
Shares Short Previous Month Date 1 B Target Median Price 88.00 Max Age 86400
Recommendation Mean 1.33 Sand P52 Week Change 0.3133 Target Mean Price 92.75
Net Income To Common -103479000 Short Percent Of Float 0.0627 Implied Shares Outstanding 29 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 288960
Average Volume10days 288960 Total Cash 487 M Next Fiscal Year End 1 B
Held Percent Insiders 0.1248 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 62.65 Target Low Price 70.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 53.42 Open 62.76
Free Cashflow -54264500 State MA Dividend Yield 0.00 %
Return On Assets -0.1791 Time Zone Short Name EST Trailing Eps -3.95
Day Low 61.62 Address1 321 Arsenal Street Shares Outstanding 29 M
Price Hint 2 Target High Price 118.00 Website https://www.discmedicine.com
52 Week Change 0.1698 Average Volume 298834 Forward Eps -5.26
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 1913.30 %
Last Split Factor 1:30 Regular Market Day High 65.42 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 0.3820 Fifty Two Week High 77.60
Day High 65.42 Shares Short 1 M Regular Market Open 62.76
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0552 Operating Cashflow -84149000 Currency USD
Time Zone Full Name America/New_York Market Cap 1 B Is_nasdaq_100 False
Zip 02472 Quote Type EQUITY Industry Biotechnology
Long Name Disc Medicine, Inc. Regular Market Day Low 61.62 Held Percent Institutions 0.9773
Current Price 64.55 Address2 Suite 101 Enterprise To Ebitda -11.51
Financial Currency USD Current Ratio 19.36 Industry Disp Biotechnology
Number Of Analyst Opinions 12 Country United States Float Shares 15 M
Two Hundred Day Average 47.26 Enterprise Value 1 B Forward PE -12.19
Regular Market Volume 136997 Ebitda -124712000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis.

Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders.

The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases.

Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.